File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Transvenous atrial defibrillation - Techniques and clinical applications

TitleTransvenous atrial defibrillation - Techniques and clinical applications
Authors
Issue Date1999
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.clinicalcardiology.org
Citation
Clinical Cardiology, 1999, v. 22 n. 10, p. 614-622 How to Cite?
AbstractAtrial fibrillation (AF) is the most common arrhythmia requiring treatment. The most desirable therapy may be restoration and maintenance of sinus rhythm. Limitations of the current methods for cardioversion of AF have prompted the development of transvenous atrial defibrillation (TADF) as an alternative and more effective technique for converting AF. Recent advances in the technique of TADF, particularly in the design and configuration of the electrodes, and the use of an optimal biphasic shock waveform have dramatically improved the efficacy of TADF for the termination of all types of AF. The reduction in voltage and energy requirements for cardioversion by TADF may allow the procedure to be performed with little or no sedation and the risk of general anesthesia may be avoided. Both experimental and clinical studies have demonstrated the feasibility, safety, and efficacy of using TADF as a new temporary or 'permanent' mode of electrical therapy for AF. It has several potential applications, from acute termination of AF in the electrophysiology laboratory and in patients who have failed to respond to external cardioversion, to its use as an implantable device for treating recurrent AF. This article reviews the current technique and clinical applications of TADF for treatment of AF.
Persistent Identifierhttp://hdl.handle.net/10722/162304
ISSN
2015 Impact Factor: 2.431
2015 SCImago Journal Rankings: 1.309
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorTse, HFen_US
dc.contributor.authorLau, CPen_US
dc.contributor.authorCamm, AJen_US
dc.date.accessioned2012-09-05T05:18:46Z-
dc.date.available2012-09-05T05:18:46Z-
dc.date.issued1999en_US
dc.identifier.citationClinical Cardiology, 1999, v. 22 n. 10, p. 614-622en_US
dc.identifier.issn0160-9289en_US
dc.identifier.urihttp://hdl.handle.net/10722/162304-
dc.description.abstractAtrial fibrillation (AF) is the most common arrhythmia requiring treatment. The most desirable therapy may be restoration and maintenance of sinus rhythm. Limitations of the current methods for cardioversion of AF have prompted the development of transvenous atrial defibrillation (TADF) as an alternative and more effective technique for converting AF. Recent advances in the technique of TADF, particularly in the design and configuration of the electrodes, and the use of an optimal biphasic shock waveform have dramatically improved the efficacy of TADF for the termination of all types of AF. The reduction in voltage and energy requirements for cardioversion by TADF may allow the procedure to be performed with little or no sedation and the risk of general anesthesia may be avoided. Both experimental and clinical studies have demonstrated the feasibility, safety, and efficacy of using TADF as a new temporary or 'permanent' mode of electrical therapy for AF. It has several potential applications, from acute termination of AF in the electrophysiology laboratory and in patients who have failed to respond to external cardioversion, to its use as an implantable device for treating recurrent AF. This article reviews the current technique and clinical applications of TADF for treatment of AF.en_US
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.clinicalcardiology.orgen_US
dc.relation.ispartofClinical Cardiologyen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAtrial Fibrillation - Therapyen_US
dc.subject.meshDefibrillators, Implantableen_US
dc.subject.meshElectric Countershock - Methodsen_US
dc.subject.meshElectrodesen_US
dc.subject.meshElectroencephalographyen_US
dc.subject.meshHumansen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleTransvenous atrial defibrillation - Techniques and clinical applicationsen_US
dc.typeArticleen_US
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_US
dc.identifier.authorityTse, HF=rp00428en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid10526684-
dc.identifier.scopuseid_2-s2.0-0032835726en_US
dc.identifier.hkuros54851-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0032835726&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume22en_US
dc.identifier.issue10en_US
dc.identifier.spage614en_US
dc.identifier.epage622en_US
dc.identifier.isiWOS:000082875000004-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridTse, HF=7006070805en_US
dc.identifier.scopusauthoridLau, CP=7401968501en_US
dc.identifier.scopusauthoridCamm, AJ=7202602504en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats